Introduction
============

Digestive diseases commonly occur in Koreans and account for 1/3 of internal diseases \[[@B1]\]. There are many kinds of digestive diseases which include bowel disorders, liver diseases, gallbladder and pancreatic diseases, digestive malignant, functional bowel disorders, reflux esophagitis, gastric ulcer, irritable bowel syndrome, gastric cancer, colorectal cancer. The number of Korean patients diagnosed with these diseases are continuously increasing.

Gastritis refers to an inflammation of a lining of the stomach. Gastritis may occur suddenly (acute gastritis), or it can occur slowly over time (chronic gastritis). Especially, patients of chronic gastritis have a wide range of symptoms in the gastric tissues. Main causes of chronic gastritis are infection with bacteria, primarily *Helicobacter pylori*, chronic bile reflux, and stress; certain diet factors such as spicy, hot, and coarse foods which irritate gastric mucosa \[[@B2],[@B3]\]. In Korea, an infection of *Helicobacter pyroli* is highly prevalent in gastritis patients and seems to be a cause of the incidence of gastric cancer \[[@B4]\]. Therefore, proper treatment including taking antiacids or therapeutic diets such as avoiding hot and spicy foods are important to prevent chronic gastritis from transfering to gastric cancer.

According to previous studies long-term intake of sufficient amount of fruits and vegetables significantly reduces the risk of gastric carcinoma \[[@B5],[@B6],[@B7]\]. It is anticipated that natural antioxidants are involved in this effect in addition to other substances. Epidemiological research \[[@B8]\] and several meta-analyses have demonstrated that high intake of salted, pickled, or smoked foods, as well as dried fish and meat and refined carbohydrates, significantly increased the risk of developing gastric cancer while fibers, fresh vegetables, and fruits were inversely associated with gastric cancer risk \[[@B7],[@B9],[@B10],[@B11],[@B12]\]. However, clinical researches on dietary factor affecting gastritis in chronic gastritis patients are rarely conducted. Since *Helicobacter pylori* infection is a main causal factor of chronic gastritis \[[@B3]\], studies to investigate the dietary studies to investigate the dietary causal factors of chronic gastritis have mainly focused on the relation between *Helicobacter pylori* and diet \[[@B2],[@B13],[@B14]\]. Although some causal dietary factors trigger chronic gastritis, having chronic gastritis may also alter dietary intake of the patients for avoiding or alleviating the symptoms.

The purpose of this study was to investigate dietary intake status and difference of biomarkers of serum lipid and redox status in chronic gastritis patients and the healthy subjects. To achieve the goal of this study we compared daily food and nutrient intake, serum glucose and lipids, and urinary oxidative biomarkers between case patients with chronic gastritis and healthy control subjects.

Materials and Methods
=====================

Subjects
--------

Participants in this research were recruited among Korean adults living in Daecheon, Korea. The subjects agreed to provide their personal information, blood, and urine according to the purpose and the procedures of this study. Subjects who had any diseases other than chronic gastritis and who took any medicines and supplements for such diseases were excluded from this research. Nineteen subjects (11 males and 8 females) who were diagnosed with chronic gastritis using stomach endoscopy and the patient\'s description of their symptoms by a medical doctor, were assigned to a case group. Twenty-seven subjects (11 males and 16 females) without associated diseases of gastrointestinal tract were assigned to a control group. There was no significant difference of gender and age distribution between the two groups. The age range of each group was over thirties to seventies. This study was approved by the Institutional Review Board of Sungshin Women\'s University and all subjects provided written informed consent (IRB-2010-018).

Anthropometric assessments
--------------------------

Height was measured without shoes using a height stadiometer, while body weight, body fat, and lean body mass were measured using InBody (X-SCAN PLUS II, Biospace, Seoul, Korea) by well-trained research staffs. Abdominal visceral fat areas were measured by computed tomography scan (HighSpeed Advantage, General Electric Co., Evansville, IN, USA). Circumference of waist and hip were measured using a tape measure while the subject was standing up. Waist circumference was determined by measuring just above the bony landmark where one finger can fit between the iliac crest and the lowest rib, and hip circumference was determined by measuring the widest circumference of the buttocks. All measurements were repeated twice and averaged value of two-time measurement were reported. Body mass index (BMI) was calculated as weight in kilograms divided by squared height in meters. Waist-to-hip ratio (WHR) was calculated as waist circumference divided by hip circumference.

Dietary intake survey
---------------------

The dietary intake survey was conducted using a 24-hr recall method through personal interviews by well-trained research staffs. Briefly, the types and amount of all foods consumed for breakfast, lunch, dinner, and snacks from rising in the morning until bedtime of the day before the survey were recorded. Food models and photographs were used to help subjects in estimating the amount of foods consumed. Daily intakes of total energy and nutrients were analyzed using Can-Pro 3.0 (The Korean Nutrition Society, Seoul, Korea).

Collection of blood and urine
-----------------------------

Twelve-hr urine on the day of the dietary intake survey and 20 mL fasting venous blood after 12-hrs fasting on the following morning were collected using a urine collection bottle and vacuum blood collection tube, respectively. Serum was separated by centrifugation at × 400 g for 15 minutes. Urine and serum were stored at -70℃ until the test was conducted.

Analysis of biochemical indices
-------------------------------

Serum glucose and lipids were analyzed using an autoanalyzer (ADVIA 1650, Bayer, Massachusetts, USA) based on enzymatic principle. In urinary oxidative biomarkers, malondialdehyde (MDA) was analyzed using HPLC (501 Waters, Massachusetts, USA), and 8-hydroxydeoxyguanosine (8-OHdG) was analyzed by microplate reader (Bio Tek, Winooski, VT, USA) with an ELISA kit. Urinary MDA and 8-OHdG were expressed as contents per g creatinine.

Statistical analysis
--------------------

Data of all results were expressed as the mean and standard deviation using the SAS program (version 9.3; SAS Institute Inc., Cary, NC, USA). Differences between case and control groups were assessed using the Student\'s unpaired t-test. Statistical significance was set at a value of p \< 0.05.

Results
=======

General characteristics
-----------------------

General characteristics of the patients with chronic gastritis are shown in [Table 1](#T1){ref-type="table"}. As shown, there was no significant difference of all characteristics including age, height, weight, BMI, and blood pressure between the two groups.

Dietary intakes
---------------

In [Table 2](#T2){ref-type="table"}, daily energy intakes were 1,900.6 kcal for the chronic gastritis patient group and 1,931.8 kcal for the normal control group without differences. No significant difference was found between the two groups in all nutrient intakes except cholesterol. The mean cholesterol intake of the chronic gastritis patients was 158.6 mg/day, and significantly lower than that of the normal control group (308.7 mg/day, p \< 0.05). The chronic gastritis group consumed significantly less sugars than the normal control group while, they tended to consume more starchy foods, such as potatoes and legumes, than the normal control group ([Table 3](#T3){ref-type="table"}).

Serum glucose and lipids
------------------------

Difference of serum glucose and lipids between case and control groups is shown in [Table 4](#T4){ref-type="table"}. The serum level of triglycerides of the chronic gastritis group (149.3 mg/dL) was significantly higher than that of normal control group (99.2 mg/dL, p \< 0.05). Nine subjects in the chronic gastritis group had a level of triglycerides higher than 150 mg/dL, however, only three subjects in the control group had a level of triglycerides higher than 150 mg/dL (data not shown).

Urinary oxidative biomarkers
----------------------------

Differences in the concentrations of urinary MDA and 8-OHdG between case and control groups are shown in [Table 5](#T5){ref-type="table"}. There was no significant differences of urinary oxidative biomarkers between the two groups.

Discussion
==========

We found that chronic gastritis patients consumed lower amount of cholesterol and sugars with greater amount of starchy foods than control subjects. As this study is planned as a cross-sectional design, it is difficult to determine cause-effect relationships between the dietary factors and chronic gastritis. However, it is postulated that the patients with chronic gastritis might have changed their diet for treatment or for alleviating the symptoms related to gastritis.

Moreover, food affects gastric motility and acid secretion. It is known that the concentrated carbohydrates result in stimulation of osmoreceptors and act on retardation of stomach deflation. Foods with high fat act on retardation of gastric emptying and the broths with large quantities of purine raise the acid secretion \[[@B2]\]. Therefore, concentrated carbohydrates and foods with high simple sugar and high fat are not recommended.

In the nutritional intake assessment, we did not find any significant differences in daily intakes of energy and nutrients in the chronic gastritis patients compared to those in the healthy control group except cholesterol intake. The daily energy intake of the chronic gastritis patient group was 1,900.6 kcal or 86.3% of Estimated Energy Requirement \[[@B15]\], which are not significantly different from those of the normal group. Meanwhile, the average daily cholesterol intake of the chronic gastritis group (158.6 mg) was significantly lower than that of the normal control group (308.7 mg). It is likely that low consumption of animal food such as meats, eggs, fish and shellfishes, and milk is associated with low cholesterol intake in the chronic gastritis subjects. Indeed, the total intake of animal food was lower than that of the control group (p = 0.05, data not shown). Although, cholesterol intakes of the two groups were significantly different; the mean cholesterol intake of the normal group was still in reasonable range, the level of serum cholesterol between the two groups were not significantly different.

In this study, the chronic gastritis group (149.3 mg/dL) had a significantly higher serum triglyceride level than normal control group (99.2 mg/dL). It can be postulated that high starchy foods consumption may be associated with elevated serum triglycerides in the chronic gastritis subjects. High carbohydrate consumption has been reported to cause hyperinsulinemia, postprandial hyperglycemia, and hypertriglyceridemia in South Asian adults \[[@B16]\]. Several epidemiological studies have also reported that low fat and high carbohydrate consumption is associated with cardiovascular disease \[[@B17],[@B18]\]. A recent study \[[@B19]\] suggested that undesirable macronutrient composition in diet consumption may be due to excessive intake of carbohydrates and that a high sodium intake may contribute to an elevated risk of metabolic syndrome as well as cardiac dysfunction in Asian populations.

It has been reported that oxidative and inflammatory status is involved in the occurrence of various chronic diseases. Chronic gastritis is an inflammatory disease and the formation of ulcerative lesions in gastrointestinal tract may be mediated by oxygen-derived free radicals \[[@B20],[@B21],[@B22]\]. In the present study, we compared urinary MDA and 8-OHdG as oxidative biomarkers between chronic gastritis patients and the control group. Findings showed no significant difference of oxidative biomarkers between the two groups, indicating no change of oxidative status in chronic gastritis. Nevertheless, it was shown that antioxidants have a protective effect against gastritis. Kim \[[@B23]\] reported that administration of *Portulaca oleracea*, as a free radical scavenger, had a antioxidant effect and protective function against the HCl-ethanol induced gastric lesion suggesting a possibility of using a radical scavenger as medication for gastritis and gastric ulcer. Further research specifically on oxidative status and protective effects of antioxidants in gastritis patients is necessary.

Our study has a few limitations. First, as mentioned above, the cross-sectional nature of this study did not allow us to determine causal relationships among the dietary factors, biomarkers, and chronic gastritis. Second, dietary intake data estimated based on a 24-hr recall method might have not captured long-term intake patterns. Lastly, the size of the sample in both the chronic gastritis and normal control groups was not large enough to have statistical power for the results of dietary intake and several biomarkers. However, to our knowledge, this study suggests that the dietary pattern of chronic gastritis patients may be associated with a change in serum lipid level.

Conclusion
==========

In this study the chronic gastritis patients consumed lower amount of cholesterol and sugars but greater amount of starchy food. They also had a higher serum triglyceride concentration compared with the normal group. These results indicate a possible relationship between a dietary pattern of chronic gastritis patients and a change in serum lipid level; however, more systematic research with a larger sample is required.
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###### Physical characteristics of the patients with chronic gastritis

![](cnr-4-90-i001)

  Variables                  Patients with chronic gastritis (n = 19)   Control subjects (n = 27)   p value^\*^
  -------------------------- ------------------------------------------ --------------------------- -------------
  Age, years                 54.37 ± 12.75                              50.74 ± 10.53               0.2975
  Height, cm                 161.80 ± 8.40                              160.77 ± 9.75               0.7082
  Weight, kg                 63.81 ± 11.37                              63.07 ± 11.78               0.8344
  Body mass index, kg/m^2^   24.26 ± 3.10                               24.27 ± 3.40                0.9972
  Body fat, %                26.08 ± 5.92                               25.63 ± 6.43                0.8100
  Lean body mass, kg         43.48 ± 8.57                               43.32 ± 9.10                0.0911
  Visceral fat area, cm^2^   99.53 ± 46.16                              79.07 ± 33.15               0.1559
  Waist-to-hip ratio         0.88 ± 0.08                                0.85 ± 0.07                 0.0869
  Systolic BP, mmHg          121.79 ± 13.63                             122.96 ± 15.39              0.7910
  Diastolic BP, mmHg         77.05 ± 9.61                               76.70 ± 12.35               0.9184

Values are presented as mean ± SD.

^\*^Determined by Student\'s t-test.

###### Daily energy and nutrient intakes of the patients with chronic gastritis

![](cnr-4-90-i002)

  Variables             Patients with chronic gastritis (n = 19)   Control subjects (n = 27)   p value^†^
  --------------------- ------------------------------------------ --------------------------- ------------
  Energy, kcal          1900.61 ± 752.26                           1931.77 ± 1178.15           0.9214
  Protein, g            69.09 ± 32.01                              74.44 ± 45.87               0.6698
  Lipid, g              29.28 ± 21.19                              45.82 ± 40.01               0.0788
  Carbohydrate, g       336.71 ± 134.57                            308.89 ± 176.91             0.5743
  Fiber, g              23.34 ± 15.04                              20.82 ± 13.37               0.5586
  Ca, mg                466.83 ± 311.33                            514.47 ± 324.12             0.6262
  P, mg                 960.82 ± 461.94                            1021.07 ± 635.72            0.7315
  Fe, mg                16.12 ± 13.86                              13.97 ± 9.66                0.5419
  Na, mg                5030.36 ± 2350.19                          5665.07 ± 3620.90           0.5153
  K, mg                 2479.51 ± 1429.17                          2587.65 ± 1597.69           0.8178
  Zn, mg                9.36 ± 4.82                                8.51 ± 4.70                 0.5602
  Vit A, ug RE          516.26 ± 587.69                            725.08 ± 613.44             0.2617
  Vit B1, mg            1.04 ± 0.52                                1.15 ± 0.70                 0.5823
  Vit B2, mg            0.87 ± 0.65                                1.15 ± 0.71                 0.1829
  Vit B6, mg            1.84 ± 0.96                                1.73 ± 1.23                 0.7675
  Niacin, mg NE         14.04 ± 7.81                               14.66 ± 10.13               0.8274
  Vit C, mg             77.35 ± 61.28                              73.01 ± 51.08               0.7976
  Folate, ug DFE        262.38 ± 171.24                            263.79 ± 189.57             0.9799
  Vit E, mg α-TE        8.86 ± 5.81                                10.10 ± 9.94                0.6002
  Cholesterol, mg^\*^   158.58 ± 184.63                            308.74 ± 240.70             0.0303

Values are presented as mean ± SD.

RE: retinol equivalents, NE: niacin equivalents, DFE: dietary folate equivalents, α-TE: α-tocopherol equivalents.

^\*^p \< 0.05; ^†^Determined by Student\'s t-test.

###### Daily food intakes of the patients with chronic gastritis

![](cnr-4-90-i003)

  Variables                 Patients with chronic gastritis (n = 19)   Control subjects (n = 27)   p value^†^
  ------------------------- ------------------------------------------ --------------------------- ------------
                            g/day                                                                  
  Cereals                   492.10 ± 179.34                            492.13 ± 355.77             0.9997
  Potato & starches         34.48 ± 44.70                              21.20 ± 47.30               0.3511
  Sugars & sweeteners^\*^   1.06 ± 2.05                                3.31 ± 4.95                 0.0419
  Legumes^\*^               93.82 ± 119.49                             21.09 ± 27.34               0.0205
  Nuts & seeds              0.13 ± 0.33                                5.94 ± 24.89                0.2363
  Vegetables                323.84 ± 238.87                            344.26 ± 283.57             0.8026
  Fungi & mushrooms         0.40 ± 1.32                                0.33 ± 1.73                 0.8921
  Fruits                    29.00 ± 90.98                              22.07 ± 58.05               0.7766
  Meats                     28.62 ± 63.52                              38.16 ± 55.78               0.5977
  Eggs                      17.31 ± 37.56                              28.00 ± 37.05               0.3509
  Fish & shellfishes        63.35 ± 84.48                              95.99 ± 129.01              0.3500
  Seaweeds                  0.70 ± 2.56                                4.54 ± 17.21                0.2633
  Milk                      20.00 ± 84.85                              60.67 ± 128.66              0.2450
  Oils & fat                3.69 ± 5.06                                4.12 ± 6.69                 0.8167
  Beverages                 25.50 ± 105.96                             30.10 ± 96.64               0.8811
  Seasoning                 44.26 ± 40.45                              32.70 ± 23.70               0.2847
  Total                     1178.26 ± 530.79                           1204.68 ± 640.15            0.8855

Values are presented as mean ± SD.

^\*^p \< 0.05; ^†^Determined by Student\'s t-test.

###### Serum glucose and lipid profile of the patients with chronic gastritis

![](cnr-4-90-i004)

  Variables                  Patients with chronic gastritis (n = 19)   Control subjects (n = 27)   p value^†^
  -------------------------- ------------------------------------------ --------------------------- ------------
  Glucose, mg/dL             97.32 ± 29.79                              99.93 ± 25.03               0.7491
  HbA1c, %                   6.02 ± 1.19                                6.11 ± 1.21                 0.8006
  Total cholesterol, mg/dL   207.63 ± 30.47                             200.74 ± 29.58              0.4464
  Triglyceride, mg/dL^\*^    149.32 ± 82.31                             99.19 ± 56.71               0.0184
  HDL-cholesterol, mg/dL     54.37 ± 11.93                              53.00 ± 11.64               0.6995
  LDL-cholesterol, mg/dL     125.32 ± 27.47                             125.00 ± 24.26              0.9673

Values are presented as mean ± SD.

HbA1c: hemoglobin A1c, HDL-cholesterol: high density lipoprotein-cholesterol, LDL-cholesterol: low density lipoprotein-cholesterol.

^\*^p \< 0.05; ^†^Determined by Student\'s t-test.

###### Urinary oxidative biomarkers of the patients with chronic gastritis

![](cnr-4-90-i005)

  Variables                 Patients with chronic gastritis (n = 19)   Control subjects (n = 27)   p value^\*^
  ------------------------- ------------------------------------------ --------------------------- -------------
  MDA, umol/g creatinine    1.73 ± 0.86                                1.54 ± 0.61                 0.3980
  8-OHdG, ug/g creatinine   3.28 ± 3.32                                3.97 ± 2.66                 0.6473

Values are presented as mean ± SD.

MDA: malondialdehyde, 8-OHdG: 8-hydroxydeoxyguanosine.

^\*^Determined by Student\'s t-test.
